Leaders from Yunnan Cell Engineering Center Co., Ltd. Visit Shenzhen Cell Valley for Exchange

Date:04-24  Hits:  Belong to:News

图片.png

Recently, Dr. Ma Bo, Chairman of Yunnan Cell Engineering Center Co., Ltd., and Dr. Liu Xin, General Manager, visited Shenzhen Cell Valley for exchange and discussion. Our Chairman, Professor Shi Yuanyuan; Deputy General Manager, Tang Xiaomeng; Quality Management Director, Zhang Xuefeng; and Deputy Head of Marketing, Yang Jianglong, extended a warm welcome to the delegation.

图片.png

图片.png

First, accompanied by Assistant to the Chairman Wei Zheng, Director of the General Administration Office Luan Zhishi, and Deputy Director of Quality Management Li Rongyou, Chairman Ma Bo and General Manager Liu Xin toured the smart exhibition hall, production workshops, and R&D laboratories, gaining an initial understanding of Shenzhen Cell Valley's strategic layout, team capabilities, core technologies, product pipelines, and quality control systems.

During the symposium, the two sides engaged in discussions on the current status and market demand of the cell industry, as well as research and clinical applications.

图片.png

Chairman Shi Yuanyuan provided a detailed introduction to the company's core technology—the industrial-scale production advantages of retroviral vectors and advanced cell preparation technologies. Chairman Shi noted that the next 20 years will be the era of cell therapy, and the application of non-genetically modified immune cells (such as high-purity, high-expansion NK cells and γδT cells) will become a key pillar of clinical treatment for major diseases, drawing significant attention in cancer prevention, anti-aging, and immune function enhancement.

Chairman Ma Bo highly acknowledged the company's technological breakthroughs and contributions in clinical treatment for cancers and other diseases. He introduced that Yunnan Cell Engineering Center Co., Ltd., through the introduction of leading domestic cell quality testing and uation technologies, has jointly established five major centers with various professional companies in Yunnan Province: shared cell storage, cell preparation, quality testing and uation, health and medical product application and physical examination, and cell industry innovation achievement transformation. The center is a technology-sharing platform capable of providing comprehensive services across the entire cell industry chain.

Both parties expressed their commitment to actively seek opportunities for cooperation in the cell industry, jointly build platforms for cell therapy development, promote integrated innovation in the cell industry between the two regions, and work together to provide patients with more high-quality, precise, and efficient medical services.

(Group photo)

图片.png


图片.png

About Yunnan Cell Engineering Center Co., Ltd. (YNCEC)

Yunnan Cell Engineering Center Co., Ltd. (YNCEC) is a limited liability company established in accordance with modern enterprise requirements by Shiguangji Biotechnology Co., Ltd. and Kunming National High-tech Industrial Development Zone State-owned Assets Management Co., Ltd. The company currently occupies a facility with a floor area of 55,000 square meters, dedicated to building a first-class technology sharing platform and cGMP advanced manufacturing platform for the cell industry. Combining "independent innovation + introduction of technology and products," the company focuses on constructing three major technology centers in Kunming High-tech Zone: "Cell Storage, Cell Preparation, and Cell Quality Testing and uation." Through close collaboration with the government, industry associations, and universities, it establishes a cell science education base and an international cell industry transfer and exchange center, attracting high-end talent and high-quality projects in the cell industry, providing project incubation and industrial support, and jointly building a cell industry cluster.


About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact:Ms. Lai

Email:laijiaqi@sz-cell.com

Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Shenzhen Cell Valley Biopharmaceutical Co., Ltd. is a leading one-stop comprehensive outsourcing service provider for China’s cell and gene therapy industry. It is also among the first domestic CRO/CDMO enterprises to hold GMP-compliant industrial production capabilities for clinical-grade retroviral vectors. As a key project for the construction of Shenzhen’s public technical service platform for CRO/CDMO, the company has been listed in the city’s newly announced "20+8" strategic emerging industries initiative.
Shenzhen Cell Valley is equipped with the capacity to conduct standardized and industrialized production of GMP-grade cellular products including CAR-T cells. Its core production lines cover a full spectrum of cellular products such as CAR-T, CAR-NK, CAR-M, γδT, TIL and TCR-T. In addition, the company runs production lines for a diverse range of viral vectors (including RVV, LVV and AAV) and non-viral vectors, as well as for cellular raw materials for therapeutic development—such as exosomes, genetically engineered antibodies, cytokines, oncolytic viruses and vaccines.